Citation: Jp. Le Floch et al., Interest of Clinitek (R) microalbumin in screening for microalbuminuria: Results of a multicentre study in 302 diabetic patients, DIABETE MET, 27(1), 2001, pp. 36-39
Authors:
Lievre, M
Menard, J
Bruckert, E
Cogneau, J
Delahaye, F
Giral, P
Leitersdorf, E
Luc, G
Masana, L
Moulin, P
Passa, P
Pouchain, D
Siest, G
Citation: M. Lievre et al., Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility, BR MED J, 322(7286), 2001, pp. 603-605
Authors:
Ducimetiere, P
Signeyrole, D
Giral, P
Hoog-Labouret, N
Amarenco, P
Chanu, B
Chauvenet, M
Coletti, M
Dallongeville, J
Durlach, V
Kawka, G
Krempf, M
Leroux, G
Mlika-Cabanne, N
Monnier, L
Paillard, F
Rostoker, G
Sicard, D
Verny, C
Voiriot, P
Acquart, B
Alquier, G
Ankri, J
Badoc, G
Basdevant, A
Belmin, J
Berthezene, F
Beucler, I
Blanc, F
Broustet, JP
Bruckert, E
Brun, JM
Castaigne, A
Charpentier, JM
Andre, MC
Cogneau, J
Demeaux, JL
Denolle, T
Desson, JF
Drahi, E
Drouin, P
Dumel, F
Emmerich, J
Farnier, M
Fontbonne, A
Forette, B
Gambert, P
Gautier, JC
Guillausseau, PJ
Hommel, M
Janowski, M
Le Goaziou, MF
Lievre, M
Le Quere, M
Leys, D
Marechaud, R
Mas, JL
Menard, J
Michel, JM
Mounier-Vehier, F
Mottier, D
Passa, P
Pinel, JF
Puel, J
Raccah, D
Renou, P
Ribier, A
Schlienger, JL
Thomas, D
Vallee, JP
Veyssier-Belot, C
Bouvenot, G
Abadie, E
Alexandre, JM
Belorgey-Bismut, C
Bergmann, JF
Camelli, B
Caulin, C
Costagliola, D
Denis, C
Dupuis, B
Fleurette, F
Guillevin, L
Hoog-Labouret, N
Paintaud, G
Rauss, A
Poynard, T
Rostoker, G
Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Citation: B. Charbonnel et P. Passa, Blood glucose peaks: An update - Diabete-Grenoble 2000 - Bayer Pharma, Satellite Symposium, 23th Marth 2000, DIABETE MET, 26, 2000, pp. 5-5
Authors:
Hadjadj, S
Gallois, Y
Simard, G
Bouhanick, B
Passa, P
Grimaldi, A
Drouin, P
Tichet, J
Marre, M
Citation: S. Hadjadj et al., Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein, NEPH DIAL T, 15(12), 2000, pp. 1971-1976
Authors:
Marre, M
Lievre, M
Vasmant, D
Gallois, Y
Hadjadj, S
Reglier, JC
Chatellier, G
Mann, J
Viberti, GC
Passa, P
Citation: M. Marre et al., Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa, DIABET CARE, 23, 2000, pp. B40-B48
Authors:
Lacquemant, C
Gaucher, C
Delorme, C
Chatellier, G
Gallois, Y
Rodier, M
Passa, P
Balkau, B
Mazurier, C
Marre, M
Froguel, P
Citation: C. Lacquemant et al., Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type 1 diabetes, KIDNEY INT, 57(4), 2000, pp. 1437-1443
Authors:
Rerolle, JP
Thervet, E
Desgrandchamps, F
Nochy, D
Janin, A
Fornairon, S
Passa, P
Bedrossian, J
Legendre, C
Citation: Jp. Rerolle et al., Histologic evolution of kidney graft after combined pancreas-kidney transplantation, TRANSPLAN P, 32(2), 2000, pp. 423-424
Authors:
James, RW
Leviev, I
Ruiz, J
Passa, P
Froguel, P
Garin, MCB
Citation: Rw. James et al., Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients, DIABETES, 49(8), 2000, pp. 1390-1393
Authors:
Brun, JM
Passa, P
Sauvanet, JP
Berthezene, F
Komajda, M
Citation: Jm. Brun et al., Proceedings of the annual symposium organised by the ALFEDIAM in conjunction with the Societe Francaise de Cardiologie and the ARCOL held in Paris, France, December 4, 1998 - Foreword, DIABETE MET, 25, 1999, pp. 5-6
Citation: P. Passa, Should the coronary diabetic patient benefit from specific management? Theviewpoint of the diabetologist., DIABETE MET, 25, 1999, pp. 58-64
Authors:
Charbonnel, B
Aptel, I
Amouyel, P
Attali, JR
Aulanier, S
Balarac, N
Bukowski, JV
Cathelineau, B
de Broucker, T
Denis, C
Mausset, J
Ormieres, JJ
Passa, P
Paulhan, A
Pousset, F
Pouteil-Noble, C
Laversin, S
Anouchian, P
Aquino, JP
Aubert, JP
Baufine-Ducrocq, H
Bernard, MH
Bonnet, A
Chabassol, E
Cirioni, A
Colas, C
Cordonnier, D
Coscas, G
Cuvelier, D
Dany, F
Derrien, G
Desrousseaux, B
Dueymes, JM
Dupasquier, JP
Dussart, L
Gemez-Lestradet, C
Gerson, M
Grimaldi, A
Gros, M
Guerot, C
Guyot-Argenton, C
Halimi, S
Kourilsky, O
Laneelle, D
Laudet, J
Lelong, S
Malinsky, M
Meffre, C
Moulin, P
Olaya, E
Razongles, P
Said, G
Vague, P
Citation: B. Charbonnel et al., Follow-up of type 2 diabetes patients (excluding complications), PRESSE MED, 28(19), 1999, pp. 1023-1027